| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $185.2M | +237.4% |
| Cost of Revenue | $138.7M | +208.0% |
| Gross Profit | $46.5M | +371.5% |
| R&D Expense | $1.8M | +28.7% |
| SG&A Expense | $47.3M | +123.4% |
| Operating Income | -$2.6M | +79.8% |
| Interest Expense | $3.4M | +20.1% |
| Pre-tax Income | -$10.5M | +38.2% |
| Income Tax | $3.3M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.9M | +33.3% |
| Accounts Receivable | $29.6M | +41.7% |
| Inventory | $51.6M | +146.7% |
| Current Assets | $108.5M | +76.8% |
| Total Assets | $201.4M | +43.9% |
| Current Liabilities | $54.7M | +35.5% |
| Long-term Debt | $51.9M | +110.7% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.3M | +50.0% |
| Investing Cash Flow | -$34.0M | -175.0% |
| Financing Cash Flow | $41.1M | -37.3% |
| +497.8% |
| Net Income | -$13.8M | +14.5% |
| EPS (Basic) | -$0.23 | +41.0% |
| EPS (Diluted) | -$0.23 | +41.0% |
| Total Liabilities |
| $119.6M |
| +79.6% |
| Stockholders' Equity | $53.3M | +19.9% |